Try our Advanced Search for more refined results

Expert Analysis

Off-Label Promotion Still A Litigation Risk For Pharma Cos.

By Dae Lee and Jesse Dresser (March 20, 2019, 1:25 PM EDT) -- In the past several years, we have seen an evaluation of the First Amendment in the federal courts pertaining to the off-label promotion of the pharmaceutical and medical device products. Information or the ability to communicate information is particularly important in health care because it may assist or help health care providers to establish the optimal patient care....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!